News
BCTXZ
0.0799
-10.63%
-0.0095
BriaCell adds ovarian cancer immunotherapy candidate Bria-OVA+ to pipeline
PUBT · 1d ago
BRIACELL EXPANDS PIPELINE TO INCLUDE AN OVARIAN CANCER IMMUNOTHERAPY CANDIDATE, BRIA-OVA+™
Reuters · 1d ago
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
Barchart · 2d ago
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
Barchart · 3d ago
BriaCell Phase 3 Bria-IMT breast cancer trial enrollment tops 230 patients
PUBT · 4d ago
BRIACELL THERAPEUTICS CORP - INTERIM TOPLINE DATA FROM PHASE 3 BRIA-ABC STUDY EXPECTED IN 2026
Reuters · 4d ago
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
Barchart · 5d ago
BriaCell adds NYU Langone Perlmutter as site for Phase 3 breast cancer trial
PUBT · 05/07 11:31
BRIACELL ADDS NYU LANGONE HEALTH’S PERLMUTTER CANCER CENTER AS CLINICAL SITE IN PIVOTAL PHASE 3 BREAST CANCER STUDY
Reuters · 05/07 11:31
BriaCell wins FDA clearance to start Bria-BRES+ metastatic breast cancer study
PUBT · 05/06 11:32
BRIACELL THERAPEUTICS CORP - TO INITIATE PHASE 1/2A STUDY OF BRIA-BRES+ IN COMING MONTHS
Reuters · 05/06 11:30
BriaCell to present final Phase 2 Bria-IMT survival data at ASCO 2026
PUBT · 04/27 11:30
BriaCell Announces Six Clinical Data Presentations at ASCO 2026
Barchart · 04/27 06:30
BriaCell plans Bria-OTS+ clinical entry in metastatic breast, prostate cancers later this year
PUBT · 04/21 11:31
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models
Barchart · 04/21 06:30
BriaCell says Phase 3 Bria-IMT plus checkpoint inhibitor preserves quality of life
PUBT · 04/20 11:31
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting
Barchart · 04/20 06:30
BriaPro buys BriaCell soluble CD80 cancer therapy license, BriaCell stake rises to 78%
Reuters · 03/31 20:07
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/18 11:30
More
Webull provides a variety of real-time BCTXZ stock news. You can receive the latest news about Briacell Therapeutics Corp through multiple platforms. This information may help you make smarter investment decisions.